Amylyx Pharmaceuticals, Inc. (AMLX)
38.14
-0.52
(-1.35%)
USD |
NASDAQ |
Aug 24, 16:00
38.14
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals 1 Year Total Returns (Daily) : 358.6% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 358.6% |
| August 20, 2026 | 393.9% |
| August 19, 2026 | 393.6% |
| August 18, 2026 | 339.4% |
| August 17, 2026 | 167.9% |
| August 14, 2026 | 157.2% |
| August 13, 2026 | 170.8% |
| August 12, 2026 | 184.8% |
| August 11, 2026 | 202.2% |
| August 10, 2026 | 196.7% |
| August 07, 2026 | 191.1% |
| August 06, 2026 | 195.4% |
| August 05, 2026 | 167.1% |
| August 04, 2026 | 174.7% |
| August 03, 2026 | 161.4% |
| July 31, 2026 | 152.9% |
| July 30, 2026 | 160.4% |
| July 29, 2026 | 148.2% |
| July 28, 2026 | 144.7% |
| July 27, 2026 | 139.1% |
| July 24, 2026 | 121.8% |
| July 23, 2026 | 109.7% |
| July 22, 2026 | 124.9% |
| July 21, 2026 | 125.3% |
| July 20, 2026 | 109.2% |
| Date | Value |
|---|---|
| July 17, 2026 | 114.4% |
| July 16, 2026 | 101.9% |
| July 15, 2026 | 119.0% |
| July 14, 2026 | 116.4% |
| July 13, 2026 | 126.7% |
| July 10, 2026 | 140.5% |
| July 09, 2026 | 153.9% |
| July 08, 2026 | 156.2% |
| July 07, 2026 | 168.8% |
| July 06, 2026 | 185.2% |
| July 02, 2026 | 178.1% |
| July 01, 2026 | 180.0% |
| June 30, 2026 | 180.2% |
| June 29, 2026 | 195.4% |
| June 26, 2026 | 173.7% |
| June 25, 2026 | 178.6% |
| June 24, 2026 | 165.2% |
| June 23, 2026 | 226.1% |
| June 22, 2026 | 222.4% |
| June 18, 2026 | 207.3% |
| June 17, 2026 | 186.1% |
| June 16, 2026 | 176.7% |
| June 15, 2026 | 175.2% |
| June 12, 2026 | 164.3% |
| June 11, 2026 | 156.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Pfizer Inc. | 16.73% |
| Eli Lilly & Co. | 77.98% |
| Merck & Co., Inc. | 83.18% |
| EyePoint, Inc. | -54.14% |
| Bristol Myers Squibb Co. | 44.96% |